Profession

ISCT’s new president talks platforms, regulation, and knowledge-transfer for the next generation

How one CDMO navigated the pandemic and came out on top of industry trends

What happened at ISCT 2022’s return to in-person conferencing – and what can a new film release do for advanced therapy?

Members of The Medicine Maker 2022 Power List reveal fascinating facts about themselves.

Tom Mander, Chief Executive Officer of Domainex looks back on his career in small molecules and shares his hopes for the future.

Academia-industry collaboration doesn’t have to be difficult; we just need to appreciate one another’s differences.

This is the story of how DNDi put forward a new model for collaborative, open science.

What links the DNDi and one of Google’s most futuristic AI assets? We get the story from DeepMind’s protein premier.

Two friends, two countries; one disease, one network to fight it. We spoke to two leaders of DNDi’s Leishmaniasis East Africa Network.

What are the biggest lessons that the pharma industry has learned from the COVID-19 pandemic?